-+ 0.00%
-+ 0.00%
-+ 0.00%

B. Riley Securities Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $81

Benzinga·11/10/2026 17:45:29
Listen to the news
B. Riley Securities analyst Madison El-Saadi maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target from $70 to $81.